Seres Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold MCRB, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
12
Funds holding
$1611677
Total value held
Buying
6 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $875790 | 111000 | +8974 | +8.80% |
| 2 | State Street Corp | $267479 | 33901 | — | Held |
| 3 | Goldman Sachs Group Inc | $120157 | 15229 | +15229 | NEW BUY |
| 4 | Northern Trust Corp | $116496 | 14765 | — | Held |
| 5 | Invesco Ltd. | $102365 | 12974 | +12974 | NEW BUY |
| 6 | Morgan Stanley | $95769 | 12138 | -9562 | -44.06% |
| 7 | Jpmorgan Chase & Co | $28325 | 3636 | +3636 | NEW BUY |
| 8 | Ubs Group Ag | $3818 | 484 | +484 | NEW BUY |
| 9 | Barclays Plc | $1318 | 167 | -6340 | -97.43% |
| 10 | Amalgamated Financial Corp. | $81 | 11332 | +11332 | NEW BUY |
| 11 | Wells Fargo & Company/Mn | $79 | 10 | — | Held |
| 12 | Royal Bank Of Canada | $0 | 11 | -96 | -89.72% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.